Role and future applications of extracellular vesicles in HIV-1 pathogenesis

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Douglas WW, Nagasawa J, Schulz RA. Coated microvesicles in neuro-secretory terminals of posterior pituitary glands shed their coats to become smooth ‘synaptic’ vesicles. Nature 232(5309), 340–341 (1971).
  Medline CASGoogle Scholar
• 2 Trams EG, Lauter CJ, Salem N Jr, Heine U. Exfoliation of membrane ecto-enzymes in the form of micro-vesicles. Biochim. Biophys. Acta 645(1), 63–70 (1981).
  Medline CASGoogle Scholar
• 3 Johnstone RM, Adam M, Hammond JR, Orr L, Turbide C. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J. Biol. Chem. 262(19), 9412–9420 (1987).
  Medline CASGoogle Scholar
• 4 Taylor DD, Homesley HD, Doellgast GJ. Binding of specific peroxidase-labeled antibody to placental-type phosphatase on tumor-derived membrane fragments. Cancer Res. 40(11), 4064–4069 (1980).
  Medline CASGoogle Scholar
• 5 Mathivanan S, Simpson RJ. ExoCarta: a compendium of exosomal proteins and RNA. Proteomics 9(21), 4997–5000 (2009).
  Medline CASGoogle Scholar
• 6 Raposo G, Nijman HW, Stoorvogel W et al. B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183(3), 1161–1172 (1996).
  Medline CASGoogle Scholar
• 7 Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9(6), 654–659 (2007).
  Medline CASGoogle Scholar
• 8 Zitvogel L, Regnault A, Lozier A et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat. Med. 4(5), 594–600 (1998).
  Medline CASGoogle Scholar
• 9 Dalton AJ. Microvesicles and vesicles of multivesicular bodies versus ‘virus-like’ particles. J. Natl Cancer Inst. 54(5), 1137–1148 (1975).
  Medline CASGoogle Scholar
• 10 Nguyen DG, Booth A, Gould SJ, Hildreth JE. Evidence that HIV budding in primary macrophages occurs through the exosome release pathway. J. Biol. Chem. 278(52), 52347–52354 (2003).• First characterization of exosomes and HIV-1.
  Medline CASGoogle Scholar
• 11 ExoCarta. www.exocarta.org/.
  Google Scholar
• 12 Exosomics Siena SpA. www.exosomics.eu.
  Google Scholar
• 13 HansaBioMed. www.hansabiomed.eu.
  Google Scholar
• 14 Exosome Diagnostics. www.exosomedx.com.
  Google Scholar
• 15 Caris Life Sciences. www.carislifesciences.com.
  Google Scholar
• 16 Aethlon Medical (Exosome Sciences). www.aethlonmedical.com.
  Google Scholar
• 17 Systembio. www.systembio.com.
  Google Scholar
• 18 Invitrogen. www.lifetechnologies.com.
  Google Scholar
• 19 Robbins PD, Morelli AE. Regulation of immune responses by extracellular vesicles. Nat. Rev. Immunol. 14(3), 195–208 (2014).•• Excellent review concerning extracellular vesicles.
  Medline CASGoogle Scholar
• 20 Thery C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 9(8), 581–593 (2009).
  Medline CASGoogle Scholar
• 21 Corrado C, Raimondo S, Chiesi A, Ciccia F, De Leo G, Alessandro R. Exosomes as intercellular signaling organelles involved in health and disease: basic science and clinical applications. Int. J. Mol. Sci. 14(3), 5338–5366 (2013).
  Medline CASGoogle Scholar
• 22 Pant S, Hilton H, Burczynski ME. The multifaceted exosome: biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities. Biochem. Pharmacol. 83(11), 1484–1494 (2012).
  Medline CASGoogle Scholar
• 23 Vlassov AV, Magdaleno S, Setterquist R, Conrad R. Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim. Biophys. Acta 1820(7), 940–948 (2012).
  Medline CASGoogle Scholar
• 24 Meckes DG Jr, Gunawardena HP, Dekroon RM et al. Modulation of B-cell exosome proteins by gamma herpesvirus infection. Proc. Natl Acad. Sci. USA 110(31), E2925–E2933 (2013).
  Medline CASGoogle Scholar
• 25 Pegtel DM, Cosmopoulos K, Thorley-Lawson DA et al. Functional delivery of viral miRNAs via exosomes. Proc. Natl Acad. Sci. USA 107(14), 6328–6333 (2010).• First demonstration showing that exosomes can deliver functional miRNA to bystander cells.
  Medline CASGoogle Scholar
• 26 Ramakrishnaiah V, Thumann C, Fofana I et al. Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells. Proc. Natl Acad. Sci. USA 110(32), 13109–13113 (2013).
  Medline CASGoogle Scholar
• 27 Feng Z, Hensley L, Mcknight KL et al. A pathogenic picornavirus acquires an envelope by hijacking cellular membranes. Nature 496(7445), 367–371 (2013).
  Medline CASGoogle Scholar
• 28 Stoorvogel W, Kleijmeer MJ, Geuze HJ, Raposo G. The biogenesis and functions of exosomes. Traffic 3(5), 321–330 (2002).
  Medline CASGoogle Scholar
• 29 Izquierdo-Useros N, Puertas MC, Borras FE, Blanco J, Martinez-Picado J. Exosomes and retroviruses: the chicken or the egg? Cell Microbiol. 13(1), 10–17 (2011).
  Medline CASGoogle Scholar
• 30 Cantin R, Diou J, Belanger D, Tremblay AM, Gilbert C. Discrimination between exosomes and HIV-1: purification of both vesicles from cell-free supernatants. J. Immunol. Methods 338(1–2), 21–30 (2008).• Separation and purification of exosomes by velocity gradient and by immunocapture using antiacetylcholinesterase antibodies.
  Medline CASGoogle Scholar
• 31 Subra C, Burelout C, Proulx S, Simard S, Gilbert C. Elimination of exosomes increase in vitro infectivity of HIV-1: implications for CD4⁺ lymphocyte depletion in vivo. In: AIDS. InTech, NY, USA (2011).
  Google Scholar
• 32 Lenassi M, Cagney G, Liao M et al. HIV Nef is secreted in exosomes and triggers apoptosis in bystander CD4⁺ T cells. Traffic 11(1), 110–122 (2010).• First demonstration that exosomes can induce apoptosis and cellular activation on bystander cells, in the context of HIV-1 infection.
  Medline CASGoogle Scholar
• 33 Narayanan A, Iordanskiy S, Das R et al. Exosomes derived from HIV-1-infected cells contain trans-activation response element RNA. J. Biol. Chem. 288(27), 20014–20033 (2013).
  Medline CASGoogle Scholar
• 34 Arenaccio C, Chiozzini C, Columba-Cabezas S et al. Exosomes from human immunodeficiency virus type 1 (HIV-1)-infected cells license quiescent CD4⁺ T lymphocytes to replicate HIV-1 through a Nef- and ADAM17-dependent mechanism. J. Virol. 88(19), 11529–11539 (2014).
  MedlineGoogle Scholar
• 35 Arenaccio C, Chiozzini C, Columba-Cabezas S, Manfredi F, Federico M. Cell activation and HIV-1 replication in unstimulated CD4⁺ T lymphocytes ingesting exosomes from cells expressing defective HIV-1. Retrovirology 11, 46 (2014).
  MedlineGoogle Scholar
• 36 Subra C, Simard S, Mercier S et al. Dendritic cells pulsed with HIV-1 release exosomes that promote apoptosis in CD4⁺ T lymphocytes (2011). www.omicsonline.org/2155-9899/2155-9899-S7-001.digital/2155-9899-S7-001.html.
  Google Scholar
• 37 Morita E, Sundquist WI. Retrovirus budding. Annu. Rev. Cell Dev. Biol. 20, 395–425 (2004).
  Medline CASGoogle Scholar
• 38 Gould SJ, Hildreth JE, Booth AM. The evolution of alloimmunity and the genesis of adaptive immunity. Q. Rev. Biol. 79(4), 359–382 (2004).
  MedlineGoogle Scholar
• 39 Booth AM, Fang Y, Fallon JK, Yang JM, Hildreth JE, Gould SJ. Exosomes and HIV Gag bud from endosome-like domains of the T cell plasma membrane. J. Cell Biol. 172(6), 923–935 (2006).
  Medline CASGoogle Scholar
• 40 Derse D, Dorn PL, Levy L, Stephens RM, Rice NR, Casey JW. Characterization of equine infectious anemia virus long terminal repeat. J. Virol. 61(3), 743–747 (1987).
  Medline CASGoogle Scholar
• 41 Chaput N, Flament C, Viaud S et al. Dendritic cell derived-exosomes: biology and clinical implementations. J. Leukoc. Biol. 80(3), 471–478 (2006).
  Medline CASGoogle Scholar
• 42 Izquierdo-Useros N, Naranjo-Gomez M, Archer J et al. Capture and transfer of HIV-1 particles by mature dendritic cells converges with the exosome-dissemination pathway. Blood 113(12), 2732–2741 (2009).• Description of similarity between HIV-1 and exosomes trafficking in mature dendritic cells.
  Medline CASGoogle Scholar
• 43 Thery C, Regnault A, Garin J et al. Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. J. Cell Biol. 147(3), 599–610 (1999).
  Medline CASGoogle Scholar
• 44 Thery C, Boussac M, Veron P et al. Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J. Immunol. 166(12), 7309–7318 (2001).
  Medline CASGoogle Scholar
• 45 Izquierdo-Useros N, Naranjo-Gomez M, Erkizia I et al. HIV and mature dendritic cells: Trojan exosomes riding the Trojan horse? PLoS Pathog. 6(3), e1000740 (2010).
  MedlineGoogle Scholar
• 46 Wiley RD, Gummuluru S. Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection. Proc. Natl Acad. Sci. USA 103(3), 738–743 (2006).
  Medline CASGoogle Scholar
• 47 Imami N, Hardy G, Burton C et al. Immune responses and reconstitution in HIV-1 infected individuals: impact of anti-retroviral therapy, cytokines and therapeutic vaccination. Immunol. Lett. 79(1–2), 63–76 (2001).
  Medline CASGoogle Scholar
• 48 Haase AT. Early events in sexual transmission of HIV and SIV and opportunities for interventions. Annu. Rev. Med. 62, 127–139 (2011).
  Medline CASGoogle Scholar
• 49 Rosenberg ES, Billingsley JM, Caliendo AM et al. Vigorous HIV-1-specific CD4⁺ T cell responses associated with control of viremia. Science 278(5342), 1447–1450 (1997).
  Medline CASGoogle Scholar
• 50 Guadalupe M, Reay E, Sankaran S et al. Severe CD4⁺ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J. Virol. 77(21), 11708–11717 (2003).
  Medline CASGoogle Scholar
• 51 Monteiro P, Gosselin A, Wacleche VS et al. Memory CCR6⁺CD4⁺ T cells are preferential targets for productive HIV type 1 infection regardless of their expression of integrin beta7. J. Immunol. 186(8), 4618–4630 (2011).
  Medline CASGoogle Scholar
• 52 Brenchley JM, Paiardini M, Knox KS et al. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 112(7), 2826–2835 (2008).
  Medline CASGoogle Scholar
• 53 Aggarwal S, Ghilardi N, Xie MH, De Sauvage FJ, Gurney AL. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278(3), 1910–1914 (2003).
  Medline CASGoogle Scholar
• 54 Pelletier M, Maggi L, Micheletti A et al. Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 115(2), 335–343 (2010).
  Medline CASGoogle Scholar
• 55 Chang TL, Vargas J Jr, Delportillo A, Klotman ME. Dual role of alpha-defensin-1 in anti-HIV-1 innate immunity. J. Clin. Invest. 115(3), 765–773 (2005).
  Medline CASGoogle Scholar
• 56 Dobmeyer TS, Raffel B, Dobmeyer JM et al. Decreased function of monocytes and granulocytes during HIV-1 infection correlates with CD4 cell counts. Eur. J. Med. Res. 1(1), 9–15 (1995).
  Medline CASGoogle Scholar
• 57 Brenchley JM, Price DA, Douek DC. HIV disease: fallout from a mucosal catastrophe? Nat. Immunol. 7(3), 235–239 (2006).
  Medline CASGoogle Scholar
• 58 Shan L, Siliciano RF. Unraveling the relationship between microbial translocation and systemic immune activation in HIV infection. J. Clin. Invest. 124(6), 2368–2371 (2014).
  Medline CASGoogle Scholar
• 59 Marchetti G, Bellistri GM, Borghi E et al. Microbial translocation is associated with sustained failure in CD4⁺ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy. AIDS 22(15), 2035–2038 (2008).
  Medline CASGoogle Scholar
• 60 Blanchet F, Moris A, Mitchell JP, Piguet V. A look at HIV journey: from dendritic cells to infection spread in CD4+ T cells. Curr. Opin. HIV AIDS 6(5), 391–397 (2011).
  MedlineGoogle Scholar
• 61 Patterson S, Knight SC. Susceptibility of human peripheral blood dendritic cells to infection by human immunodeficiency virus. J. Gen. Virol. 68(Pt 4), 1177–1181 (1987).
  MedlineGoogle Scholar
• 62 Mcdonald D, Wu L, Bohks SM, Kewalramani VN, Unutmaz D, Hope TJ. Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science 300(5623), 1295–1297 (2003).
  Medline CASGoogle Scholar
• 63 Lambert AA, Gilbert C, Richard M, Beaulieu AD, Tremblay MJ. The C-type lectin surface receptor DCIR acts as a new attachment factor for HIV-1 in dendritic cells and contributes to trans- and cis-infection pathways. Blood 112(4), 1299–1307 (2008).
  Medline CASGoogle Scholar
• 64 Klechevsky E, Flamar AL, Cao Y et al. Cross-priming CD8⁺ T cells by targeting antigens to human dendritic cells through DCIR. Blood 116(10), 1685–1697 (2010).
  Medline CASGoogle Scholar
• 65 Raposo G, Moore M, Innes D et al. Human macrophages accumulate HIV-1 particles in MHC II compartments. Traffic 3(10), 718–729 (2002).
  Medline CASGoogle Scholar
• 66 Bodey B, Bodey B Jr, Kaiser HE. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network. In Vivo 11(4), 351–370 (1997).
  Medline CASGoogle Scholar
• 67 Andre F, Chaput N, Schartz NE et al. Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells. J. Immunol. 172(4), 2126–2136 (2004).
  Medline CASGoogle Scholar
• 68 Hsu DH, Paz P, Villaflor G et al. Exosomes as a tumor vaccine: enhancing potency through direct loading of antigenic peptides. J. Immunother. 26(5), 440–450 (2003).
  Medline CASGoogle Scholar
• 69 Quah B, O'neill HC. Review: the application of dendritic cell-derived exosomes in tumour immunotherapy. Cancer Biother. Radiopharm. 15(2), 185–194 (2000).
  Medline CASGoogle Scholar
• 70 Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22, 745–763 (2004).
  Medline CASGoogle Scholar
• 71 Groot F, Van Capel TM, Schuitemaker J, Berkhout B, De Jong EC. Differential susceptibility of naive, central memory and effector memory T cells to dendritic cell-mediated HIV-1 transmission. Retrovirology 3, 52 (2006).
  MedlineGoogle Scholar
• 72 Segura E, Nicco C, Lombard B et al. ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming. Blood 106(1), 216–223 (2005).
  Medline CASGoogle Scholar
• 73 Thery C, Duban L, Segura E, Veron P, Lantz O, Amigorena S. Indirect activation of naive CD4⁺ T cells by dendritic cell-derived exosomes. Nat. Immunol. 3(12), 1156–1162 (2002).
  Medline CASGoogle Scholar
• 74 Chatila TA, Williams CB. Regulatory T cells: exosomes deliver tolerance. Immunity 41(1), 3–5 (2014).
  Medline CASGoogle Scholar
• 75 Brenchley JM, Schacker TW, Ruff LE et al. CD4⁺ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 200(6), 749–759 (2004).
  Medline CASGoogle Scholar
• 76 Schacker TW, Brenchley JM, Beilman GJ et al. Lymphatic tissue fibrosis is associated with reduced numbers of naive CD4⁺ T cells in human immunodeficiency virus type 1 infection. Clin. Vaccine Immunol. 13(5), 556–560 (2006).
  Medline CASGoogle Scholar
• 77 Doitsh G, Galloway NL, Geng X et al. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature 505(7484), 509–514 (2013).
  Google Scholar
• 78 Gyorgy B, Szabo TG, Pasztoi M et al. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell. Mol. Life Sci. 68(16), 2667–2688 (2011).
  Medline CASGoogle Scholar
• 79 Baur AS. HIV-Nef and AIDS pathogenesis: are we barking up the wrong tree? Trends Microbiol. 19(9), 435–440 (2011).
  Medline CASGoogle Scholar
• 80 Raymond AD, Campbell-Sims TC, Khan M et al. HIV type 1 Nef is released from infected cells in CD45⁺ microvesicles and is present in the plasma of HIV-infected individuals. AIDS Res. Hum. Retroviruses 27(2), 167–178 (2010).
  MedlineGoogle Scholar
• 81 Abusamra AJ, Zhong Z, Zheng X et al. Tumor exosomes expressing Fas ligand mediate CD8⁺ T-cell apoptosis. Blood Cells Mol. Dis. 35(2), 169–173 (2005).
  Medline CASGoogle Scholar
• 82 Konadu KA, Chu J, Huang MB et al. Association of cytokines with exosomes in the plasma of HIV-1-seropositive individuals. J. Infect. Dis. doi:10.1093/infdis/jiu676 (2014) (Epub ahead of print).
  MedlineGoogle Scholar
• 83 Madison MN, Roller RJ, Okeoma CM. Human semen contains exosomes with potent anti-HIV-1 activity. Retrovirology 11(1), 102 (2014).
  MedlineGoogle Scholar
• 84 Naslund TI, Paquin-Proulx D, Paredes PT, Vallhov H, Sandberg JK, Gabrielsson S. Exosomes from breast milk inhibit HIV-1 infection of dendritic cells and subsequent viral transfer to CD4⁺ T cells. AIDS 28(2), 171–180 (2014).
  MedlineGoogle Scholar
• 85 Frleta D, Ochoa CE, Kramer HB et al. HIV-1 infection-induced apoptotic microparticles inhibit human DCs via CD44. J. Clin. Invest. 122(12), 4685–4697 (2012).
  Medline CASGoogle Scholar
• 86 Mercier SK, Donaghy H, Botting RA et al. The microvesicle component of HIV-1 inocula modulates dendritic cell infection and maturation and enhances adhesion to and activation of T lymphocytes. PLoS Pathog. 9(10), e1003700 (2013).
  MedlineGoogle Scholar
• 87 Kadiu I, Narayanasamy P, Dash PK, Zhang W, Gendelman HE. Biochemical and biologic characterization of exosomes and microvesicles as facilitators of HIV-1 infection in macrophages. J. Immunol. 189(2), 744–754 (2012).
  Medline CASGoogle Scholar
• 88 Admyre C, Johansson SM, Paulie S, Gabrielsson S. Direct exosome stimulation of peripheral human T cells detected by ELISPOT. Eur. J. Immunol. 36(7), 1772–1781 (2006).
  Medline CASGoogle Scholar
• 89 Lattanzi L, Federico M. A strategy of antigen incorporation into exosomes: comparing cross-presentation levels of antigens delivered by engineered exosomes and by lentiviral virus-like particles. Vaccine 30(50), 7229–7237 (2012).
  Medline CASGoogle Scholar
• 90 Nanjundappa RH, Wang R, Xie Y, Umeshappa CS, Xiang J. Novel CD8⁺ T cell-based vaccine stimulates Gp120-specific CTL responses leading to therapeutic and long-term immunity in transgenic HLA-A2 mice. Vaccine 30(24), 3519–3525 (2012).
  Medline CASGoogle Scholar
• 91 Nanjundappa RH, Wang R, Xie Y et al. GP120-specific exosome-targeted T cell-based vaccine capable of stimulating DC- and CD4⁽⁺⁾ T-independent CTL responses. Vaccine 29(19), 3538–3547 (2011).
  Medline CASGoogle Scholar
• 92 Ohtsuka Y, Sanderson IR. Transforming growth factor-beta: an important cytokine in the mucosal immune response. Curr. Opin. Gastroenterol. 16(6), 541–545 (2000).
  Medline CASGoogle Scholar
• 93 Nakae S, Iwakura Y, Suto H, Galli SJ. Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J. Leukoc. Biol. 81(5), 1258–1268 (2007).
  Medline CASGoogle Scholar
• 94 Seddiki N, Brezar V, Ruffin N, Levy Y, Swaminathan S. Role of miR-155 in the regulation of lymphocyte immune function and disease. Immunology 142(1), 32–38 (2013).
  Google Scholar
• 95 Lu LF, Thai TH, Calado DP et al. Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 30(1), 80–91 (2009).
  Medline CASGoogle Scholar
• 96 Koito A, Ikeda T. Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases. Front. Microbiol. 4, 28 (2013).
  Medline CASGoogle Scholar
• 97 Sheehy AM, Gaddis NC, Choi JD, Malim MH. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418(6898), 646–650 (2002).• Identification of APOBEC3G.
  Medline CASGoogle Scholar
• 98 Zhang H, Yang B, Pomerantz RJ, Zhang C, Arunachalam SC, Gao L. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424(6944), 94–98 (2003).
  Medline CASGoogle Scholar
• 99 Khatua AK, Taylor HE, Hildreth JE, Popik W. Exosomes packaging APOBEC3G confer human immunodeficiency virus resistance to recipient cells. J. Virol. 83(2), 512–521 (2009).
  Medline CASGoogle Scholar
• 100 Khatua AK, Taylor HE, Hildreth JE, Popik W. Inhibition of LINE-1 and Alu retrotransposition by exosomes encapsidating APOBEC3G and APOBEC3F. Virology 400(1), 68–75 (2010).
  Medline CASGoogle Scholar
• 101 Balaj L, Lessard R, Dai L et al. Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat. Commun. 2, 180 (2011).
  MedlineGoogle Scholar
• 102 Wurdinger T, Gatson NN, Balaj L, Kaur B, Breakefield XO, Pegtel DM. Extracellular vesicles and their convergence with viral pathways. Adv. Virol. 2012, 767694 (2012).
  MedlineGoogle Scholar